EQUILLIUM, INC. Interest Expense on Debt
EQUILLIUM, INC. (EQ) reported Interest Expense on Debt of $491.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Expense Statement
us-gaap:InterestExpenseDebt · last filed 2025-03-27
- EQUILLIUM, INC. interest expense, debt for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- EQUILLIUM, INC. interest expense, debt for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- EQUILLIUM, INC. interest expense, debt for the quarter ending 2023-06-30 was $259.00K, a 0.00% change year-over-year.
- EQUILLIUM, INC. interest expense, debt for the quarter ending 2023-03-31 was $232.00K, a 9.02% decline year-over-year.
- EQUILLIUM, INC. interest expense, debt for fiscal 2023 was $491.00K, a 53.37% decline from fiscal 2022.
- EQUILLIUM, INC. interest expense, debt for fiscal 2022 was $1.05M, a 1.86% decline from fiscal 2021.
- EQUILLIUM, INC. interest expense, debt for fiscal 2021 was $1.07M, a 2.37% decline from fiscal 2020.
- EQUILLIUM, INC. interest expense, debt for fiscal 2020 was $1.10M, a 293.91% increase from fiscal 2019.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 3 month as first filed | Interest Expense, Debt 6 month | Interest Expense, Debt 7 month | Interest Expense, Debt 9 month | Interest Expense, Debt 9 month as first filed | Interest Expense, Debt 10 month | Interest Expense, Debt 12 month | Interest Expense, Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $259.00K derived: sum of 3 quarters · filed 2025-03-27 | $491.00K 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $259.00K derived: sum of 2 quarters · filed 2024-11-13 | $491.00K 10-Q · filed 2024-11-13 | $762.00K derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $259.00K 10-Q · filed 2024-08-08 | $491.00K 10-Q · filed 2024-08-08 | $762.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.03M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | $232.00K 10-Q · filed 2024-05-09 | $503.00K derived: sum of 2 quarters · filed 2024-05-09 | $770.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.03M derived: sum of 4 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | $271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $538.00K derived: sum of 2 quarters · filed 2024-03-25 | $797.00K derived: sum of 3 quarters · filed 2024-03-25 | $1.05M 10-K · filed 2024-03-25 | |||||
| 2022-09-30 | $267.00K 10-Q · filed 2023-11-08 | $526.00K derived: sum of 2 quarters · filed 2023-11-08 | $782.00K 10-Q · filed 2023-11-08 | $1.05M derived: sum of 4 quarters · filed 2023-11-08 | |||||
| 2022-06-30 | $259.00K 10-Q · filed 2023-08-09 | $515.00K 10-Q · filed 2023-08-09 | $780.00K derived: sum of 3 quarters · filed 2023-08-09 | $1.05M derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2022-03-31 | $255.00K 10-Q · filed 2023-05-11 | $521.00K derived: sum of 2 quarters · filed 2023-05-11 | $787.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.06M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $532.00K derived: sum of 2 quarters · filed 2023-03-23 | $802.00K derived: sum of 3 quarters · filed 2023-03-23 | $1.07M 10-K · filed 2023-03-23 | |||||
| 2021-09-30 | $266.00K 10-Q · filed 2022-11-14 | $536.00K derived: sum of 2 quarters · filed 2022-11-14 | $807.00K 10-Q · filed 2022-11-14 | $1.08M derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | $270.00K 10-Q · filed 2022-08-15 | $541.00K 10-Q · filed 2022-08-15 | $817.00K derived: sum of 3 quarters · filed 2022-08-15 | $1.09M derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2021-03-31 | $271.00K 10-Q · filed 2022-05-12 | $547.00K derived: sum of 2 quarters · filed 2022-05-12 | $823.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.10M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $552.00K derived: sum of 2 quarters · filed 2022-03-23 | $826.00K derived: sum of 3 quarters · filed 2022-03-23 | $1.10M 10-K · filed 2022-03-23 | |||||
| 2020-09-30 | $276.00K 10-Q · filed 2021-11-10 | $550.00K derived: sum of 2 quarters · filed 2021-11-10 | $823.00K 10-Q · filed 2021-11-10 | $1.10M derived: sum of 4 quarters · filed 2021-11-10 | |||||
| 2020-06-30 | $274.00K 10-Q · filed 2021-08-10 | $547.00K 10-Q · filed 2021-08-10 | $824.00K derived: sum of 3 quarters · filed 2021-08-10 | $826.00K derived: sum of 4 quarters · filed 2021-08-10 | |||||
| 2020-03-31 | $273.00K 10-Q · filed 2021-05-13 | $550.00K derived: sum of 2 quarters · filed 2021-05-13 | $552.00K derived: sum of 3 quarters · filed 2021-05-13 | ||||||
| 2019-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $279.00K derived: sum of 2 quarters · filed 2021-03-24 | $279.00K 10-K · filed 2021-03-24 | ||||||
| 2019-09-30 | $2.00K 10-Q · filed 2020-11-10 | $2.00K 10-Q · filed 2020-11-10 | |||||||
| 2018-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $1.45M derived: sum of 2 quarters · filed 2020-03-26 | $2.07M derived: sum of 3 quarters · filed 2020-03-26 | $2.56M 10-K · filed 2020-03-26 | $2.56M 10-K · filed 2019-03-27 | ||||
| 2018-09-30 | $1.22M 10-Q · filed 2019-11-12 | $1.22M 10-Q · filed 2018-11-15 | $1.84M derived: sum of 2 quarters · filed 2019-11-12 | $2.33M 10-Q · filed 2019-11-12 | $2.33M 10-Q · filed 2018-11-15 | ||||
| 2018-06-30 | $619.00K 10-Q · filed 2019-08-12 | $1.11M 10-Q · filed 2019-08-12 | |||||||
| 2018-03-31 | $489.00K 10-Q · filed 2019-05-13 | ||||||||
| 2017-12-31 | $379.38K 10-K · filed 2019-03-27 | ||||||||
| 2017-09-30 | $15.12K 10-Q · filed 2018-11-15 | $22.19K 10-Q · filed 2018-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |